This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the clinical trials in his lab are revealing about the potential these compounds hold for the treatment of depression, addiction, trauma, eating disorders, ADHD, and other disorders of the mind. Dr. Johnson describes a typical psychedelic experiment in his laboratory, start to finish, including the conditions for optimal clinical outcomes. And he explains some of the potential hazards and common misconceptions and pitfalls related to psychedelic medicine. Dr. Johnson explains flashbacks, the heightened risks of certain people and age groups using psychedelics and the ever evolving legal and pharmaceutical industry landscape surrounding psychedelics. Dr. Johnson also explains how the scientific study of psychedelics is likely to set the trajectory of psychiatric medicine in the years to come. Dr. Johnson is among a small handful of researchers who have pioneered the clinical study of these powerful compounds. He has unprecedented insight into how they can be woven into other psychiatric treatments, changing ones sense of self and of reality.
Thank you to our sponsors:
Athletic Greens – n
Belcampo – n
InsideTracker – n
Dr. Matthew Johnson Social Media:
Twitter: r
Instagram: r
Our Patreon page:
n
Supplements from Thorne:
n
Social:
Instagram – b
Twitter – b
Facebook – b
Website – m
Newsletter – k
Links:
Dr. Johnson’s Website at Johns Hopkins School of Medicine – n
Chris Letheby’s forthcoming book –
Timestamps:
00: 00: 00 Introducing Dr. Matthew Johnson
00: 02: 10 Supporting Sponsors
00: 06: 40 ‘Psychedelics’ Defined
00: 14: 09 Hallucinations, Synesthesia, Altered Space-Time Perception
00: 19: 56 Serotonin & Dopamine
00: 23: 50 Ketamine & Glutamate
00: 28: 00 An Example Psychedelic Experiment
00: 37: 30 ‘Letting Go’ with Psychedelics
00: 44: 10 Our Mind’s Eye
00: 48: 00 Redefining Your Sense of Self
00: 58: 56 Exporting Psychedelic Learnings to Daily Life
01: 04: 36 Flashbacks
01: 12: 10 Ayahuasca, & ASMR, Kundalini Breathing
01: 15: 54 MDMA, DMT
01: 26: 00 Dangers of Psychedelics, Bad Trips, Long-Lasting Psychosis
01: 38: 15 Micro-Dosing
01: 56: 45 Risks for Kids, Adolescents & Teenagers; Future Clinical Trials
02: 03: 40 Legal Status: Decriminalization vs. Legalization vs. Regulation
02: 18: 35 Psychedelics for Treating Concussion & Traumatic Brain Injury
02: 27: 45 Shifting Trends in Psychedelic Research, Academic Culture
02: 44: 23 Participating in a Clinical Trial, Online Survey Studies, Breathwork
02: 50: 38 Conclusions, Subscribing & Supporting the HLP, Supplements
Please note that The Huberman Lab Podcast is distinct from Dr. Huberman’s teaching and research roles at Stanford University School of Medicine. The information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Huberman Lab Podcast, its employees, guests and affiliates assume no liability for the application of the information discussed.
Title Card Photo Credit: Mike Blabac – m
